385 related items for PubMed ID: 11174215
1. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
Nelson HS.
J Allergy Clin Immunol; 2001 Feb; 107(2):398-416. PubMed ID: 11174215
[Abstract] [Full Text] [Related]
2. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[Abstract] [Full Text] [Related]
3. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza Rosenzweig JR.
J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
[Abstract] [Full Text] [Related]
4. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.
Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, Knobil K.
J Allergy Clin Immunol; 2000 Dec; 106(6):1088-95. PubMed ID: 11112891
[Abstract] [Full Text] [Related]
5. Does measuring BHR add to guideline derived clinical measures in determining treatment for patients with persistent asthma?
Koenig SM, Murray JJ, Wolfe J, Andersen L, Yancey S, Prillaman B, Stauffer J, Dorinsky P.
Respir Med; 2008 May; 102(5):665-73. PubMed ID: 18328683
[Abstract] [Full Text] [Related]
6. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Delea TE, Hagiwara M, Stanford RH, Stempel DA.
Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
[Abstract] [Full Text] [Related]
7. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[Abstract] [Full Text] [Related]
8. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S, Vogelmeier C, Buhl R.
Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
[Abstract] [Full Text] [Related]
9. [Asthma control with the salmeterol-fluticasone-combination disc compared to standard treatment].
Molitor S, Liefring E, Trautmann M.
Pneumologie; 2005 Mar 15; 59(3):167-73. PubMed ID: 15756629
[Abstract] [Full Text] [Related]
10. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, Dorinsky P.
Ann Allergy Asthma Immunol; 2005 Jul 15; 95(1):66-71. PubMed ID: 16095144
[Abstract] [Full Text] [Related]
11. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
Baumgarten C, Geldszus R, Behre U, Peslis N, Trautmann M, Viani-Initial Study Group.
Eur J Med Res; 2002 Jan 29; 7(1):1-7. PubMed ID: 11827834
[Abstract] [Full Text] [Related]
12. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
COPD; 2007 Jun 29; 4(2):127-34. PubMed ID: 17530506
[Abstract] [Full Text] [Related]
13. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A, Jarvis B.
Drugs; 2000 Nov 29; 60(5):1207-33. PubMed ID: 11129128
[Abstract] [Full Text] [Related]
14. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
Kimura T, Adachi M.
Nihon Rinsho; 2001 Oct 29; 59(10):1992-9. PubMed ID: 11676144
[Abstract] [Full Text] [Related]
15. Combination therapy in asthma--fixed or variable dosing in different patients?
Lötvall J.
Curr Med Res Opin; 2004 Nov 29; 20(11):1711-27. PubMed ID: 15537472
[Abstract] [Full Text] [Related]
16. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
Stempel DA, Riedel AA, Carranza Rosenzweig JR.
Curr Med Res Opin; 2006 Mar 29; 22(3):463-70. PubMed ID: 16574030
[Abstract] [Full Text] [Related]
17. Efficacy and safety of fluticasone propionate/salmeterol 250/50 mcg Diskus administered once daily.
Kerwin EM, Nathan RA, Meltzer EO, Ortega HG, Yancey SW, Schoaf L, Dorinsky PM.
Respir Med; 2008 Apr 29; 102(4):495-504. PubMed ID: 18206361
[Abstract] [Full Text] [Related]
18. Combination therapy with the single inhaler salmeterol/fluticasone propionate versus increased doses of inhaled corticosteroids in patients with asthma.
Li HT, Zhang TT, Zhou H, Qu XJ, Wu WM, Huang J.
Respiration; 2007 Apr 29; 74(1):33-43. PubMed ID: 17008769
[Abstract] [Full Text] [Related]
19. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
Perrin K, Williams M, Wijesinghe M, James K, Weatherall M, Beasley R.
J Allergy Clin Immunol; 2010 Sep 29; 126(3):505-10. PubMed ID: 20816187
[Abstract] [Full Text] [Related]
20. A retrospective study of the use of fluticasone propionate/salmeterol combination as initial asthma controller therapy in a commercially insured population.
Friedman H, Wilcox T, Reardon G, Crespi S, Yawn BP.
Clin Ther; 2008 Oct 29; 30(10):1908-17. PubMed ID: 19014847
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
